job details posted 13. June 2022 location zug sector life sciences job type permanent reference number 17688 contact audrey bisch, basel professionals health care & life sciences phone 058 201 55 50 apply now email job description Do you want to work in a big pharmaceutical company? Do you have a first experience as a Medical Scientific Liaison? You should then read the following lines! Our client, based in Zug, is looking for a Medical Scientific Liaison for a permanent positionYour ResponsibilitiesAs a medical-scientific expert in immunology, you always keep your comprehensive knowledge of the therapy area, new treatment options and studies up to date and make it available to all internal stakeholders within the organization.You are actively involved in the development, detailed planning, coordination and implementation of the Medical Affairs Plan, including the medical budget, and thus also in the short and long-term achievement of corporate goals.Responsible for creating the MSL activity plan tailored to the needs of the Leading Specialists and aligned with the continuing education strategy.Execute the MSL activity plans in close collaboration with Commercial, Sales and HEMAR.You will process medical-scientific content for all portfolio of products.Internal interface between different departments within the organization as well as the EMEA Medical Affairs organizations to create strategic value for the company through proactive information exchange.You keep knowledge of the therapy area up to date, for example by attending congressesYour ProfileMD, Pharma or PhD DegreeFirst professional experience in Immunology (Rheumatology, Dermatology, Gastro)Knowledge of the KOL on the swiss marketStrong skills in research and interpretation of medical data.Ability to challenge the status quoFluency in English is mandatory, German and/or French is a strong advantage. Do not waste any minutes, apply now! We are looking forward to receiving your application.Please note that only candidates with a valid work permit or who are EU/EFTA citizens will be considered. share: Facebook LinkedIn Twitter Xing